Scientific Insights Center
Explore a collection of webinars, abstracts and publications, white papers, and video content. Gain key insights to deepen your understanding and stay updated on our autoimmune and allergy technologies and solutions.
Published Scientific Communications
Analytical Performance of a Novel Automated Immunoassay Microarray analyzing simultaneously 5 markers associated with Celiac Disease. ACG2024.
This study assesses the analytical performance of a novel automated immunoassay microarray for autoantibodies associated with Celiac Disease. Presented at ACG 2024.
Learn more
Performance characteristics of Automated Immunoassay Microarray prototype detecting Centromere Protein B (CENP-B). AACC2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting Anti-Centromere Protein B (CENP-B) antibodies. Presented at AACC 2023.
Learn more
Performance characteristics of Automated Immunoassay Microarray detecting Anti-Centromere Protein B antibodies. Immunochemistry & Immunopathology 2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting Anti-Centromere Protein B (CENP-B) antibodies.
Learn more
Performance characteristics of Automated Immunoassay Microarray prototype analyzing simultaneously 11 IgG markers associated with Connective Tissue Diseases. ACR2023.
This study assesses the performance characteristics of a novel automated immunoassay microarray for detecting 11 IgG antibodies associated with Connective Tissue Diseases. Presented at ACR 2023.
Learn more
Analytical Performance of a Novel Automated Immunoassay Microarray analyzing simultaneously 15 markers associated with Connective Tissue Diseases. IFCC2024.
This study assesses the analytical performance of a novel automated immunoassay microarray for detecting 15 IgG antibodies associated with Connective Tissue Diseases. Presented at IFCC2024.
Learn more
Analytical Evaluation of Automated Immunoassay Microarray analyzing simultaneously 11 markers associated with Connective Tissue Diseases in a Spanish Reference Laboratory. ADLM2024.
This study assesses the analytical performance of a novel automated immunoassay microarray for detecting 11 antibodies associated with Connective Tissue Diseases, in a Spanish Reference Laboratory. Presented at ADLM2024.
Learn more
Automated Immunoassay Microarray for Detecting Bet v 1-Specific IgE: Performance & Findings from ECI 2024
This study assesses a fully automated immunoassay microarray for detecting Bet v 1-specific IgE, offering improved accuracy and efficiency in allergy diagnostics. Presented at ECI 2024.
Learn moreWebinars
LumiQ™ System Demonstration
Introducing LumiQ: An all-in-one Immunofluorescence (IFA) solution.
Watch now
MosaiQ® System Demonstration
Discover MosaiQ: A groundbreaking IVD solution for autoimmune diseases, allergy, and beyond.
Watch now
Advances in the Serological Evaluation of Celiac Disease
In this webinar, Celiac Disease is discussed with particular focus on advances in the diagnosis and how a multiplex approach to serological testing can support the identification of the disease.
Watch nowLearn more about our solutions
Discover how our solutions can help optimize your lab’s workflow for improved efficiency.
Trending Topics
Our passion for the work we do is matched only by our commitment to consistently provide the best customer experience possible.
-
AliveDx Recertified to ISO 14001 Environmental Standard
We’re proud to announce that AliveDx has achieved recertification to ISO 14001, the international standard for Environmental Management Systems (EMS). This milestone demonstrates our ongoing commitment to reducing environmental impact, improving sustainability, and maintaining operational excellence. ISO 14001 is especially
-
AliveDx Earns Great Place To Work Certification™ in its 3 sites: Switzerland, UK and US
AliveDx is proud to be Certified™ by Great Place To Work®. The prestigious award is based entirely on what current employees say about their experience working at AliveDx. Great Place To Work® is the global authority on workplace culture, employee
-
AliveDx Suisse S.A. and Warba Medical Supplies Co. W.L.L sign two strategic distribution agreements in Kuwait
AliveDx Suisse S.A. and Warba Medical Supplies Co. W.L.L. have signed two strategic distribution agreements, which will enable Warba Medical Supplies to distribute the MosaiQ® and LumiQ® solutions in Kuwait. The distribution agreements take effect immediately. This partnership underscores AliveDx’s
-
AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, sign a distribution agreement for Australia and New Zealand
AliveDx Suisse S.A. and Bio-Strategy, part of DKSH Group, have signed a distribution agreement, which will enable Bio-Strategy to distribute the LumiQ™ solution in Australia and New Zealand. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to
-
Join us at EuroMedLab 2025
We are excited to announce our participation in the upcoming EuroMedLab Congress in Brussels, Belgium, from 19-22 May 2025. Visit us at booth #245 to learn more about our MosaiQ® and LumiQ™ innovative, turnkey, fully automated autoimmune diagnostic solutions. The
-
AliveDx Suisse S.A. and Disera Tibbi Malzeme Lojistik. san. Tic. A.S sign Distribution Agreement in Türkiye
AliveDx Suisse S.A. and Disera Tibbi Malzeme Lojistik. san. Tic. A.S have signed a distribution agreement, which will enable Disera to distribute the MosaiQ® and LumiQ™ solutions in Türkiye. The distribution agreement takes effect immediately. This strategic partnership with an
